CION Ameerpet
Staging describes how far disease has travelled, and nothing else. It is not how aggressive the cancer is — that is grade, and the two get confused constantly. Here is what each stage and substage actually means.
These two words are used almost interchangeably in ordinary conversation and they mean completely different things. Getting them straight makes everything else on a pathology report readable.
Stage is a question of geography: how far has the disease travelled? Stage 1 is confined to the ovaries. Stage 2 has reached elsewhere in the pelvis. Stage 3 has spread across the peritoneal surfaces of the abdomen or to nodes behind it. Stage 4 has gone beyond the abdominal cavity.
Grade is a question of behaviour: how abnormal do the cells look, and how fast are they dividing? Low-grade cells still resemble normal tissue and grow slowly; high-grade cells are markedly abnormal and divide rapidly. A woman can have stage 1 high-grade disease — caught early but aggressive — or stage 3 low-grade disease, which has spread widely but grows slowly. Those are entirely different situations, and neither is described by a single number. See grade explained.
How far the disease has travelled: ovary, pelvis, abdomen, beyond. Nothing about aggression.
How abnormal the cells look and how fast they divide. Nothing about how far they have spread.
Stage 1 high-grade and stage 3 low-grade are both real and both quite different situations.
Ovarian cancer is staged surgically, not radiologically — which sets it apart from many cancers where a scan determines the stage. The reason is that ovarian cancer spreads by shedding cells across the peritoneal surfaces, and deposits too small for any scan to see still change the stage and therefore the treatment. So proper staging requires systematic sampling during the operation: washings from the abdominal cavity, biopsies of peritoneal surfaces, the omentum, and lymph nodes — taken even where everything looks entirely normal. An incompletely staged operation may need repeating, which is one reason who performs the first surgery matters so much. Source: FIGO ovarian cancer staging; NCCN Ovarian Cancer guidelines.
Find the one on your report. The substage letters and numbers carry real information beyond the headline stage.
| Stage | What it means | Notes |
|---|---|---|
| IA | Confined to one ovary or tube; capsule intact; no cells in washings. | The earliest stage. Contained disease with the best outlook. |
| IB | Confined to both ovaries or tubes; capsules intact; no cells in washings. | Both sides involved but still contained. |
| IC1 | Confined, but the capsule ruptured during surgery. | Documented because rupture affects the stage. Why intact removal matters. |
| IC2 | Capsule ruptured before surgery, or tumour on the ovarian surface. | Disease had already breached the capsule before the operation. |
| IC3 | Malignant cells found in peritoneal washings or ascites. | Cells have escaped into the abdominal cavity, even without visible deposits. |
| IIA | Extension to the uterus or fallopian tubes. | Spread within the pelvis but no further. |
| IIB | Extension to other pelvic tissues. | Still confined to the pelvis. |
| IIIA1 | Retroperitoneal lymph nodes only, confirmed microscopically. | The least extensive stage 3. Peritoneum not visibly involved. |
| IIIA2 | Microscopic peritoneal spread beyond the pelvis. | Deposits found only on examining sampled tissue. |
| IIIB | Visible peritoneal deposits beyond the pelvis, 2 cm or smaller. | Visible but limited. Complete removal often achievable. |
| IIIC | Visible deposits larger than 2 cm, or involving liver or spleen surface. | The commonest substage at diagnosis. |
| IVA | Malignant cells in fluid around the lung. | Often the only feature placing a woman at stage 4. The fluid is drainable. |
| IVB | Spread beyond the abdomen, or within liver or spleen substance. | Includes distant nodes and organ involvement outside the abdominal cavity. |
*A recurring distinction worth knowing: deposits on the surface of the liver or spleen are stage 3, because the surface is peritoneal. Disease inside those organs is stage 4.
Stage is not a label. It drives specific decisions, and knowing which ones helps make sense of your plan.
This is the clearest consequence. Very early, low-grade disease that was completely removed and properly staged may need no chemotherapy — surgery alone can be sufficient. That is a genuinely different situation from most ovarian cancer, and it depends entirely on the staging having been done thoroughly.
This is precisely why incomplete staging matters. If washings, peritoneal biopsies and nodes were not sampled, nobody can be confident the disease is truly stage I — and chemotherapy may then be given because the uncertainty cannot be resolved. See stage 1.
At stage 3 and 4, the question becomes whether all visible disease can be removed at the outset. Where imaging suggests it can, primary surgery followed by chemotherapy is usually preferred. Where it cannot, chemotherapy is given first to shrink the disease, with interval surgery following.
This decision rests largely on the CT scan rather than on the stage number itself, and both routes are well evidenced. Being on the chemotherapy-first pathway reflects what the imaging showed, not a judgement about how treatable your disease is.
Stages 1 to 3 are generally treated with the intent of achieving remission. At stage 4 the aim usually shifts towards meaningful control — shrinking disease, relieving symptoms and giving good time — while remission remains possible for some women.
This is worth asking about directly rather than inferring. It is a question with an honest answer, and knowing it lets you make decisions about your own time. See stage 4.
Stage matters enormously, but it is one factor among several. Grade, subtype, whether complete surgical removal was achieved, how the disease responds to platinum-based chemotherapy, and your general health all feed into the picture alongside it.
A stage 3 high-grade serous cancer that was completely resected and responds well to platinum is in a different position from one that was incompletely removed and progressed on treatment. The stage is the same number and the situations are not.
This confuses people, so it is worth stating. Your stage is set at diagnosis and does not change afterwards. If disease returns having been treated, you do not become a higher stage — you have recurrent disease of the stage you were originally.
Similarly, disease that shrinks with chemotherapy does not lower your stage. Stage is a permanent descriptor of extent at diagnosis, used for planning and for comparing outcomes across populations. See recurrence.
FIGO staging for ovarian cancer covers fallopian tube cancer and primary peritoneal cancer under the same system, because these three are now understood as closely related — most high-grade serous disease appears to begin in the fallopian tube regardless of where it is eventually found.
So a woman diagnosed with primary peritoneal or fallopian tube cancer is staged, treated and monitored in essentially the same way. See fallopian tube cancer and primary peritoneal cancer.
These establish whether your stage is on solid ground, which matters more than the number itself.
Not just the number. IIIA1 and IIIC are both stage 3 and describe very different amounts of disease.
Washings, peritoneal biopsies, omentum, lymph nodes. Complete staging requires all of them.
In apparently early disease this determines whether you are IA or IC, which changes the treatment decision.
Separate from the stage, and one of the strongest influences on outcome at stage 3.
Stage alone does not tell you enough. Grade and subtype shape what treatment can achieve.
Staging and treatment planning should be a multidisciplinary decision, not one clinician's.
If your operation did not include systematic staging samples, your stage may be less certain than it appears — and that uncertainty can itself drive a decision to give chemotherapy.
Stage is how far disease has spread. Grade is how abnormal the cells look. A low-stage high-grade cancer and a high-stage low-grade one are entirely different situations.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring your pathology and operation reports — the stage comes from what was sampled.
A stage number arrives with enormous weight attached and almost no explanation. Women are told stage 3 and left to search it, finding statistics that mix substages, subtypes and treatment eras into a figure that describes nobody in particular.
Your first consultation at CION is free and runs to about 45 minutes. Bring both your pathology report and your operation note — the stage comes from what was actually sampled during surgery, and the operation note is where that is recorded. Much of the useful work is establishing your full substage, what was sampled, and what the stage actually changes for you.
Chemotherapy and PARP-inhibitor-class maintenance therapy are delivered in-house at CION across 35+ centres in Telangana and Andhra Pradesh, alongside genetic counselling and BRCA and HRD testing. Staging and debulking surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there — arranged that way because complete surgical staging genuinely matters. Every case that raises a question goes to a tumour board.
Free and unhurried. Long enough to explain the substage and what it actually changes.
The stage comes from what was sampled during surgery, and that is recorded in the operation note.
Staging and treatment planning reviewed multidisciplinarily rather than by one clinician.
Staging and debulking at specialist gynaecologic-oncology partner centres, and may be billed there.
The first thing almost anyone does with a stage number is search for survival figures attached to it. Those numbers are real, and they mislead in ways worth understanding before you read them.
They are historical, describing women treated years ago, before PARP-inhibitor-class maintenance therapy and routine HRD testing existed. They average across substages — IIIA1 and IIIC are both stage 3 and describe very different amounts of disease. They mix subtypes, so aggressive high-grade serous and slow-growing low-grade disease sit in the same figure. And they mix women who achieved complete surgical removal with those who did not, when that factor makes a substantial difference.
CION publishes its own one-year survival alongside the national figure so the comparison is visible: 81.0% of CION ovarian cancer patients are alive at one year, against a national figure of 73.7%. That is across all stages and is a one-year figure rather than a cure rate. Your own outlook depends on your substage, grade, subtype, completeness of surgery and treatment response — which is a conversation for your oncologist rather than a search result.
CION ovarian cancer patients alive at one year from diagnosis. *One-year survival, CION treated population, all stages.
The comparable national figure. *One-year survival; national registry data, all stages.
IIIA1 and IIIC are both stage 3 and describe very different amounts of disease.
Aggressive high-grade serous and slow-growing low-grade disease sit inside the same figure.
*One-year survival rates across all stages. CION figures reflect CION's treated patient population; national figures are drawn from published Indian cancer registry data. Survival statistics describe groups rather than individuals — discuss your own prognosis with your treating oncologist.
They answer different questions and are frequently confused. Stage is geography — how far the disease has travelled, from confined to the ovary at stage 1 through to beyond the abdominal cavity at stage 4. Grade is behaviour — how abnormal the cells look under the microscope and how fast they are dividing, from low-grade cells that still resemble normal tissue and grow slowly to high-grade cells that are markedly abnormal and divide rapidly. A woman can have stage 1 high-grade disease, caught early but aggressive, or stage 3 low-grade disease, widespread but slow-growing.
Because microscopic disease changes the stage and no scan can detect it. Ovarian cancer spreads by shedding cells across the peritoneal surfaces, and deposits far too small to appear on any imaging still alter the stage and therefore the treatment. Proper staging requires systematic sampling during the operation — washings from the abdominal cavity, biopsies of the peritoneal surfaces, the omentum and lymph nodes — taken even where everything looks entirely normal to the surgeon's eye. This is also why an incompletely staged operation may need repeating, and why who performs the first surgery matters.
They carry real information beyond the headline number. Within stage 1, A means one ovary involved with the capsule intact, B means both, and C means the capsule was ruptured or malignant cells were found in washings — which changes the treatment decision. Within stage 3, IIIA1 means retroperitoneal nodes only, IIIA2 microscopic peritoneal spread, IIIB visible deposits 2 cm or smaller, and IIIC deposits larger than 2 cm or involving the liver or spleen surface. Within stage 4, IVA means fluid around the lung and IVB spread beyond the abdomen.
No. Your stage is set at diagnosis and does not change afterwards. If disease returns having been treated, you have recurrent disease of the stage you were originally diagnosed at — you do not become a higher stage. Equally, disease that shrinks substantially with chemotherapy does not lower your stage. Stage is a permanent descriptor of how far disease had extended at the time of diagnosis, used for treatment planning and for comparing outcomes across populations. What changes over time is the disease status, not the stage.
It is an important factor but far from the only one, and a stage number alone tells you considerably less than people assume. Grade, subtype, whether complete surgical removal was achieved, how the disease responds to platinum-based chemotherapy and your general health all feed into the picture alongside stage. A stage 3 cancer that was completely resected and responds well to platinum is in a very different position from one incompletely removed that progressed on treatment — same number, different situations. Your oncologist can speak to your actual circumstances.
Because the surface of the liver is peritoneal tissue, and ovarian cancer spreads across peritoneal surfaces — so a deposit sitting on the liver surface is still peritoneal spread within the abdominal cavity, which is stage 3. Disease that has grown into the substance of the liver itself is different: that represents spread into an organ rather than across a surface, and it is stage 4. The same distinction applies to the spleen. It is a genuine and consequential difference that is easily misread on a report, so it is worth asking which applies.
The first consultation is free and runs to about 45 minutes — bring both your pathology report and your operation note, since the stage comes from what was actually sampled during surgery and that is recorded in the operation note. Much of the useful work is establishing your full substage, which sites were sampled, and what the stage actually changes for you. Chemotherapy, maintenance therapy, genetic counselling and BRCA and HRD testing are delivered in-house across more than 35 centres; staging and debulking surgery is coordinated with specialist partner centres and may be billed there.